TXT’s Concert In 4DX Brings MOAs To The Edge Of Their Seats—Quite Literally

Experience music like never before in “Tomorrow X Together: Hyperfocus,” the immersive 4DX concert film featuring admired hits, available at Ayala Malls Cinemas from January 15-21.

‘iNDIEGENIUS’ Project Champions Cultural Films For The Second Time Around

With its second edition, the iNDIEGENIUS Project Lab at iACADEMY provides promising filmmakers with essential tools and support to explore Indigenous storytelling.

Weaving the Past into the Future: Cebu Pacific Promotes Philippine Textile Arts

Cebu Pacific takes a step towards preserving Philippine cultural heritage through its new initiative promoting local textile arts.

5 Financial Resolutions To Keep In The New Year

The new year brings the opportunity to reassess financial priorities and set clear goals for the months ahead.

Global Coronavirus Cases Surpass 40M

The number of the COVID-19 cases in the world has surpassed 40 million on Monday.

Global Coronavirus Cases Surpass 40M

9
9

How do you feel about this story?

Like
Love
Haha
Wow
Sad
Angry

The number of the coronavirus disease 2019 (Covid-19) cases in the world has surpassed 40 million early Monday, according to Johns Hopkins University data.

More than 1.11 million people have lost their lives around the world from Covid-19 so far.

The US still leads the world in the number of Covid-19 cases with over 8.15 million, while deaths are at almost 220,000.

In India, more than 7.55 million people contracted the virus with a death toll of over 114,600. Brazil has more than 5.22 million cases and a death toll exceeding 153,600.

China, the birthplace of Covid-19, has close to 91,000 cases with 4,739 deaths.

The UK’s Scientific Advisory Group for Emergencies said Sunday more than one coronavirus vaccine will be available at the beginning of 2021.

American pharmaceutical firm Pfizer said Friday it may know the effectiveness of its vaccine by the end of October, and it is planning to submit safety data on the final dose of the vaccine to the US Food and Drug Administration in the third week of November.

A vaccine candidate developed by the Beijing Institute of Biological Products, affiliated to the state-owned China National Pharmaceutical Group (Sinopharm), elicited antibody response in recipients, according to a study published Thursday in the Lancet Infectious Diseases journal.

Meanwhile, Russian President Vladimir Putin said Wednesday that a second coronavirus vaccine, EpiVakKorona, has been granted regulatory approval.

There are more than 170 vaccines around the world that are candidates for Covid-19 and tracked by the World Health Organization, but none has been approved for general use yet. (PNA)